1-13 of 13
Joan Bladé
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Maintenance Therapy After Stem-Cell Transplantation for Multiple Myeloma with Bortezomib/Thalidomide Vs. Thalidomide Vs. alfa2b-Interferon: Final Results of a Phase III Pethema/GEM Randomized Trial

Laura Rosiñnol, MD, Albert Oriol, Ana Isabel Teruel, Dolores Hernández, Javier Lopez-Jimenez, MD, Javier De La Rubia, MD, Miquel Granell, MD, Juan Besalduch, MD, PhD, Luis Palomera, MD, Yolanda González, MD, Maria Asunción Etxebeste, Joaquín Díaz-Mediavilla, Miguel Teodoro Hernández, Felipe de Arriba, Adrian Alegre, María Teresa Cibeira, Maria Victoria Mateos, MD, PhD, Joaquin Martinez, MD, Juan José Lahuerta, Jesús F San Miguel, Joan Bladé, MD
Journal: Blood
Blood (2012) 120 (21): 334.
https://doi.org/10.1182/blood.V120.21.334.334
Published: 2012
Journal Articles

Maintenance Therapy with Bortezomib Plus Thalidomide (VT) or Bortezomib Plus Prednisone (VP) In Elderly Myeloma Patients Included In the GEM2005MAS65 Spanish Randomized Trial

María-Victoria Mateos, MD, PhD, Albert Oriol, Ana-Isabel Teruel, Enrique Bengoechea, Montse Pérez, Javier López, Joaquín Díaz-Mediavilla, Jose Mariano Hernández, Felipe de Arriba, Yolanda Gonzalez, Joan Bladé, MD, Juan José Lahuerta, Jesðs F. San Miguel
Journal: Blood
Blood (2011) 118 (21): 477.
https://doi.org/10.1182/blood.V118.21.477.477
Published: 2011
Journal Articles

Differences in Patterns of Treatment and Outcome Among Patients with Relapsed Refractory Myeloma From United States, Europe and Asia,

Shaji Kumar, MD, Jae Hoon Lee, MD, Juan Jose Lahuerta, MD, Gareth J Morgan, MD PhD, Paul G. Richardson, MD, John Crowley, PhD, Jeff Haessler, John Feather, Antje Hoering, PhD, Philippe Moreau, MD, Xavier Leleu, MD, Cyril Hullin, MD, Saskia K. Klein, MD, PhD, Pieter Sonneveld, MD, PhD, David S. Siegel, MD, PhD, Joan Bladé, MD, Hartmut Goldschmidt, MD, Sundar Jagannath, MD, Jesus F. San Miguel, MD, PhD, Robert Z. Orlowski, MD, PhD, Antonio Palumbo, MD, Orhan Sezer, MD, PhD, S. Vincent Rajkumar, MD, Brian GM Durie, MD
Journal: Blood
Blood (2011) 118 (21): 3989.
https://doi.org/10.1182/blood.V118.21.3989.3989
Published: 2011
Journal Articles

SNP-Based Mapping Arrays Reveal High Genomic Complexity in Monoclonal Gammopathies: From the MGUS to Myeloma Status

Lucía López-Corral, Maria Eugenia Sarasquete, Sílvia Beà, Ramón García-Sanz, Maria Victoria Mateos, Marcos González, MD, Luis Antonio Corchete, Joan Bladé, MD, Albert Oriol-Rocafiguera, Miguel Hernandez, Pilar Giraldo, Jose Hernández, Jesús M Hernández-Rivas, Jesús F San Miguel, Norma C. Gutierrez
Journal: Blood
Blood (2011) 118 (21): 295.
https://doi.org/10.1182/blood.V118.21.295.295
Published: 2011
Journal Articles

Extramedullary Myeloma.

Joan Bladé, MD, Ma Teresa Cibeira, Laura Rosiñol, Carlos Fernández de Larrea
Journal: Blood
Blood (2009) 114 (22): SCI-5.
https://doi.org/10.1182/blood.V114.22.SCI-5.SCI-5
Published: 2009
Journal Articles

Impact of Baseline Free Light Chain Ratio (rFLC) On Clinical Outcomes and Change in rFLC During Treatment in Patients with Relapsed/Refractory Multiple Myeloma Treated with Pegylated Liposomal Doxorubicin Plus Bortezomib or Bortezomib Alone.

Valeria Magarotto, MD, Anil Londhe, PhD, Keith C. Lantz, MS, Colin Lowery, DPhil, Pieter Sonneveld, MD, PhD, Joan Bladé, MD, Jean-Luc Harousseau, MD, Robert Z. Orlowski, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4778.
https://doi.org/10.1182/blood.V114.22.4778.4778
Published: 2009
Journal Articles

A Phase II Study of Oral Panobinostat (LBH589) in Adult Patients with Advanced Refractory Multiple Myeloma

Jeffrey Lee Wolf, David Siegel, Jeffrey Matous, Sagar Lonial, Hartmut Goldschmidt, Stefan Schmitt, Ravi Vij, Margarida De Malgalhaes-Silverman, Rafat Abonour, Muhammad Jalaluddin, Martha Li, Katharine Hazell, Priscille M. Bourquelot, Maria-Victoria Mateos, Kenneth C. Anderson, Andrew Spencer, Jean-Luc Harousseau, Joan Bladé
Journal: Blood
Blood (2008) 112 (11): 2774.
https://doi.org/10.1182/blood.V112.11.2774.2774
Published: 2008
Journal Articles

Prognostic Value of Immunophenotyping of Multiple Myeloma: A Study on 685 Patients Uniformly Treated with High-Dose Therapy.

Gema Mateo, PhD, Maria A. Montalban, MD, Maria-Belén Vidriales, MD, Juan J. Lahuerta, MD, Maria-Victoria Mateos, MD, Norma C. Gutiérrez, MD, Laura Rosiñol, MD, Laura Montejano, MD, Ma Consuelo López-Berges, MD, Joan Bladé, MD, Rafael Martínez, MD, Javier de la Rubia, MD, Joaquín Diaz-Mediavilla, MD, Anna Sureda, MD, José M. Ribera, MD, José M. Ojanguren, MD, Felipe de Arriba, MD, Luis Palomera, MD, Ma José Terol, MD, Santiago Gardella, MD, Alberto Orfao, MD, J.F. San Miguel
Journal: Blood
Blood (2007) 110 (11): 1472.
https://doi.org/10.1182/blood.V110.11.1472.1472
Published: 2007
Journal Articles

Early Normalization of Serum Free Light Chain Is Associated with Prolonged Time to Progression Following Bortezomib ± Pegylated Liposomal Doxorubicin Treatment of Relapsed/Refractory Multiple Myeloma.

Robert Orlowski, MD, PhD, Heather Sutherland, MD, PhD, Joan Bladé, MD, Jesús San Miguel, MD, Roman Hájek, MD, PhD, Arnon Nagler, MD, MSc, Pieter Sonneveld, MD, PhD, Andrew Spencer, DM, Tadeusz Robak, MD, PhD, Suneel Mundle, PhD, Donghan Luo, PhD, Sen Hong Zhuang, MD, PhD, Jean-Luc Harousseau, MD
Journal: Blood
Blood (2007) 110 (11): 2735.
https://doi.org/10.1182/blood.V110.11.2735.2735
Published: 2007
Journal Articles

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study

Clinical Trials & Observations
María-Victoria Mateos, José-M. Hernández, Miguel-T. Hernández, Norma-C. Gutiérrez, Luis Palomera, Marta Fuertes, Joaquín Díaz-Mediavilla, Juan-J. Lahuerta, Javier de la Rubia, María-José Terol, Ana Sureda, Joan Bargay, Paz Ribas, Felipe de Arriba, Adrian Alegre, Albert Oriol, Dolores Carrera, José García-Laraña, Ramón García-Sanz, Joan Bladé, Felipe Prósper, Gemma Mateo, Dixie-Lee Esseltine, Helgi van de Velde, Jesús-F. San Miguel
Journal: Blood
Blood (2006) 108 (7): 2165–2172.
https://doi.org/10.1182/blood-2006-04-019778
Published: 2006
Journal Articles

High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA

Clinical Trials & Observations
Joan Bladé, Laura Rosiñol, Ana Sureda, Josep M. Ribera, Joaquín Díaz-Mediavilla, José García-Laraña, M. Victoria Mateos, Luis Palomera, Javier Fernández-Calvo, Josep M. Martí, Pilar Giraldo, Félix Carbonell, Manel Callís, Jesús Trujillo, Santiago Gardella, M. Jesús Moro, Abelardo Barez, Alfons Soler, Llorenç Font, Montserrat Fontanillas, Jesús San Miguel, for Programa para el Estudio de la Terapéutica en Hemopatía Maligna (PETHEMA)
Journal: Blood
Blood (2005) 106 (12): 3755–3759.
https://doi.org/10.1182/blood-2005-03-1301
Published: 2005
Journal Articles

Monoclonal Gammopathy of Undetermined Significance (MGUS): Predictors of Outcome and Recognition of an Evolving Type.

Laura Rosiñol, Joan Bladé, Ma Teresa Cibeira, Silvia Montoto, Jordi Esteve, Maria Rozman, Xabier Fililla, Emili Montserrat
Journal: Blood
Blood (2005) 106 (11): 5052.
https://doi.org/10.1182/blood.V106.11.5052.5052
Published: 2005
Journal Articles

Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcome

Brief Report
Jesús F. San Miguel, Julia Almeida, Gema Mateo, Joan Bladé, Consuelo López-Berges, Dolores Caballero, José Hernández, Marı́a Jesús Moro, Javier Fernández-Calvo, Joaquı́n Dı́az-Mediavilla, Luis Palomera, Alberto Orfao
Journal: Blood
Blood (2002) 99 (5): 1853–1856.
https://doi.org/10.1182/blood.V99.5.1853
Published: 2002